GlassScriptPhysician profile
Mallory S Roberson
NPI 1134661440
$3,490.82
in general payments reported to CMS, 2019-2025
43 companies · $21.19 in 2025
The $21.19 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $1,317 · 2023: $1,403 · 2024: $511 · 2025: $21.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,867 · Education: $68.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,866.81 |
| Education | $68.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $263.08 | 2021-2023 | Inbrija |
| Abbvie INC. | $260.04 | 2022-2023 | |
| Lilly USA, LLC | $211.44 | 2022-2024 | Emgality, Amyvid |
| Novartis Pharmaceuticals Corporation | $199.73 | 2023-2025 | |
| Lundbeck LLC | $197.78 | 2022-2024 | Vyepti, Rexulti |
| Ucb, INC. | $169.14 | 2021-2024 | Rystiggo, Briviact, Fintepla |
| Supernus Pharmaceuticals, INC. | $167.65 | 2022-2023 | |
| Argenx US, INC. | $160.69 | 2022-2024 | Vyvgart |
| Sunovion Pharmaceuticals INC. | $128.18 | 2022 | |
| Sk Life Science, INC. | $115.54 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $106.02 | 2022 | |
| Acadia Pharmaceuticals INC | $101.54 | 2022-2024 | Nuplazid |
| Amgen INC. | $101.19 | 2022-2023 | Prolia, Evenity |
| Galderma Laboratories, L.P. | $100.42 | 2021 | |
| Neurocrine Biosciences, INC. | $100.34 | 2022-2024 | Ingrezza, Ongentys |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Roberson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.